CLINICAL_TRIALS
trial_result
· 2018-12-05
Clinical Trial Update: Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer [Phase 2]
Summary
Phase II trial of everolimus with or without trastuzumab in hormone-refractory metastatic breast cancer completed; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-12-05